Avelas Biosciences
  • About Us
    • About Us
    • Our Mission
    • Executive Team
    • Board of Directors
  • Our Science
    • Our Science
    • Intraoperative Imaging Device
    • Publications
  • Our Product
    • Pegloprastide (AVB-620)
    • Pipeline
    • Clinical Trials
    • Expanded Access
  • News
  • Contact
    • Contact
    • Careers

News

  1. Oct 22, 2018

    Updates to Avelas Biosciences Management Team

    Read more
  2. Sep 26, 2018

    Avelas Biosciences to Present at 2018 Cantor Global Healthcare Conference

    Read more
  3. Aug 02, 2018

    Avelas Biosciences Initiates Period 2 of Phase 2 Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery

    Read more
  4. Jun 14, 2018

    Avelas Biosciences to Present at JMP Securities Annual Life Sciences Conference

    Read more
  5. Mar 21, 2018

    Avelas Biosciences to Present at Needham & Company 17th Annual Healthcare Conference

    Read more
  6. Mar 13, 2018

    Avelas Biosciences to Present at Oppenheimer 28th Annual Healthcare Conference

    Read more
  7. Jan 04, 2018

    Avelas Biosciences Completes Period 1 Patient Enrollment in Phase 2 Study of AVB-620 in Women with Primary, Nonrecurrent Breast Cancer Undergoing Surgery

    Read more
  8. Jan 03, 2018

    Avelas Biosciences Broadens Management Team with Key Executive Additions

    Read more
  9. Nov 21, 2017

    Avelas Biosciences to Present at Piper Jaffray Healthcare Conference

    Read more

« Previous Page — Next Page »

  • Home
  • About Us
  • Our Science
  • Our Product
  • News
  • Contact

Copyright © Avelas Biosciences | Website by AshWebStudio